Study of COVID-19 DNA Vaccine (AG0302-COVID19)
Clinical trial NCT04527081 · COMPLETED
Trial details
- NCT number
- NCT04527081
- Sponsor
- AnGes, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-31
- Primary completion
- 2020-11-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.